Ngā hua rapu - Maple M. Fung

  • E whakaatu ana i te 1 - 10 hua o te 10
Whakamahine hua
  1. 1
    Heart disease risk factors predict erectile dysfunction 25 years later

    Heart disease risk factors predict erectile dysfunction 25 years later mā Maple M. Fung, Richele Bettencourt, Elizabeth Barrett‐Connor

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Catestatin: A multifunctional peptide from chromogranin A

    Catestatin: A multifunctional peptide from chromogranin A mā Sushil K. Mahata, Manjula Mahata, Maple M. Fung, Daniel T. O’Connor

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol

    Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol mā Nicola Dalbeth, Savvas Nicolaou, Scott Baumgartner, Jia Hu, Maple M. Fung, Hyon K. Choi

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Decreased Slow Wave Sleep Increases Risk of Developing Hypertension in Elderly Men

    Decreased Slow Wave Sleep Increases Risk of Developing Hypertension in Elderly Men mā Maple M. Fung, Katherine W. Peters, Susan Redline, Michael G. Ziegler, Sonia Ancoli‐Israel, Elizabeth Barrett‐Connor, Katie L. Stone

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based Study)

    Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based S... mā Kenneth G. Saag, David Fitzpatrick, Jeff Kopicko, Maple M. Fung, Nihar Bhakta, Scott Adler, Chris Storgard, Scott Baumgartner, Michael A. Becker

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

    Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinationa... mā Thomas Bardin, Robert T. Keenan, Puja Khanna, Jeff Kopicko, Maple M. Fung, Nihar Bhakta, Scott Adler, Chris Storgard, Scott Baumgartner, Alexander So

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study

    Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study mā Anne‐Kathrin Tausche, Rieke Alten, Nicola Dalbeth, Jeff Kopicko, Maple M. Fung, Scott Adler, Nihar Bhakta, Chris Storgard, Scott Baumgartner, Kenneth G. Saag

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

    Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial mā Nicola Dalbeth, Graeme Jones, Robert Terkeltaub, Dinesh Khanna, Jeff Kopicko, Nihar Bhakta, Scott Adler, Maple M. Fung, Chris Storgard, Scott Baumgartner, Fernando Perez‐Ruiz

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in Humans<i>In Vivo</i>

    Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in Humans<i>In Vivo</i> mā Maple M. Fung, Rany M. Salem, Parag Mehtani, Brenda Thomas, Christine F. Lu, Brandon Perez, Fangwen Rao, Mats Stridsberg, Michael G. Ziegler, Sushil K. Mahata, Daniel T. O’Connor

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Heritability and Genome-Wide Linkage in US and Australian Twins Identify Novel Genomic Regions Controlling Chromogranin A

    Heritability and Genome-Wide Linkage in US and Australian Twins Identify Novel Genomic Regions Controlling Chromogranin A mā Daniel T. O’Connor, Gu Zhu, Fangwen Rao, Laurent Taupenot, Maple M. Fung, Madhusudan Das, Sushil K. Mahata, Manjula Mahata, Lei Wang, Kuixing Zhang, Tiffany A. Greenwood, Pei-an Betty Shih, Myles Cockburn, Michael G. Ziegler, Mats Stridsberg, Nicholas G. Martin, John B. Whitfield

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: